Literature DB >> 18977814

Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study.

Y Matsui1, Y Tanizaki, H Arima, K Yonemoto, Y Doi, T Ninomiya, K Sasaki, M Iida, T Iwaki, S Kanba, Y Kiyohara.   

Abstract

OBJECTIVE: To estimate the incidence and survival rates of total and cause specific dementia in a general Japanese population.
METHODS: A total of 828 subjects without dementia, aged 65 years or over, were followed-up prospectively for 17 years. Dementia was subdivided into cause specific subtypes: namely, Alzheimer's disease (AD), vascular dementia (VD), dementia with Lewy bodies (DLB), combined dementia and other types of dementia. During the follow-up, 275 subjects developed dementia; of these, 251 (91.2%) were evaluated morphologically, with 164 subjected to brain autopsy examination and the remaining 87 to neuroimaging.
RESULTS: The incidences of total dementia, AD, VD, DLB, combined dementia and other types of dementia were 32.3 (n = 275), 14.6 (124), 9.5 (81), 1.4 (12), 3.8 (33), and 3.1 (16) per 1000 person years, respectively. The incidences of AD, combined dementia and other types of dementia rose with increasing age, particularly after the age of 85 years, but this tendency was not observed for VD or DLB. The survival curve of dementia cases aged 65-89 years was significantly lower than that of age and sex matched controls (10 year survival rate, 13.6% vs 29.3%; hazard ratio 1.67; 95% confidence interval 1.31 to 2.13). The 10 year survival rates were not significantly different among dementia subtypes.
CONCLUSIONS: Our findings suggest that the Japanese elderly population has a high risk for the development of dementia, specifically AD and VD, and once dementia is established, the risk of death is considerable.

Entities:  

Mesh:

Year:  2008        PMID: 18977814     DOI: 10.1136/jnnp.2008.155481

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Trajectories of behavioral disturbance in dementia.

Authors:  Tiffany W Chow; Jonathan D Fridhandler; Malcolm A Binns; Albert Lee; Jennifer Merrilees; Howie J Rosen; Robin Ketelle; Bruce L Miller
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

Review 3.  The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Karin Lind; Åke Edman; Mattias Göthlin; Jacob Stålhammar; Marie Eckerström; Silke Kern; Anne Börjesson-Hanson; Mårten Carlsson; Erik Olsson; Henrik Zetterberg; Kaj Blennow; Johan Svensson; Annika Öhrfelt; Maria Bjerke; Sindre Rolstad; Carl Eckerström
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

4.  Parkinson's disease showing progressive conduction aphasia.

Authors:  Kenji Sakai; Kenjiro Ono; Hiromi Harada; Keisuke Shima; Masako Notoya; Masahito Yamada
Journal:  Neurol Sci       Date:  2011-08-31       Impact factor: 3.307

Review 5.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

6.  A shrinkage method for testing the Hardy-Weinberg equilibrium in case-control studies.

Authors:  Yong Zang; Ying Yuan
Journal:  Genet Epidemiol       Date:  2013-08-11       Impact factor: 2.135

Review 7.  Diabetes mellitus and dementia.

Authors:  Toshiharu Ninomiya
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

8.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

9.  α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies.

Authors:  Kensaku Kasuga; Masatoyo Nishizawa; Takeshi Ikeuchi
Journal:  Int J Alzheimers Dis       Date:  2012-09-26

10.  A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.

Authors:  Yu Nakamura; Yukimichi Imai; Masahiro Shigeta; Ana Graf; Toru Shirahase; Hyosung Kim; Akifumi Fujii; Joji Mori; Akira Homma
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.